Z
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 17 Feb 2021)
What this means for you
Registered since 03 Nov 2015. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86398253
- Registration number
- 4847465
- Mark type
- Design + words
- Filed
- 18 Sept 2014
- Published for opposition
- 03 Feb 2015
- Registered
- 03 Nov 2015
- Attorney of record
- Sarah Anne Keefe
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical and therapeutic drug development services; pharmaceutical and therapeutic drug research and development
Owner
- Zynerba Pharmaceuticals, Inc., Devon, PA, US
- Zynerba Pharmaceuticals, Inc., Devon, PA, US
- Zynerba Pharmaceuticals, Inc., Lexington, KY, US
Prosecution history
- 03 Nov 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 17 Feb 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 17 Feb 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 16 Feb 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Nov 2020 — TEAS SECTION 8 & 15 RECEIVED
- 03 Nov 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 Feb 2018 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Dec 2017 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Dec 2017 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Nov 2015 — REGISTERED-PRINCIPAL REGISTER
- 30 Sept 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Sept 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Sept 2015 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Sept 2015 — USE AMENDMENT FILED
- 26 Sept 2015 — CASE ASSIGNED TO INTENT TO USE PARALEGAL